An adult male patient on TYSABRI (300 mg, IV, QM) for Multiple Sclerosis from 13 May 2014 to 24 Jul 2015 
reported TYSABRI makes him sick and JCV virus positive (onsets unknown). Treatments were not reported and 
the outcome for the events is unknown. Causality was not assessed and TYSABRI therapy was discontinued.
Print Time: 13-JUN-2016 09:36 AM If a field is blank, there is no data for that field Page 364 of 457
FDA - Adverse Event Reporting System (FAERS) 
FOIA Case Report Information